E13.355
Other specified diabetes mellitus with stable proliferative diabetic retinopathy
Clinical Classification Guidelines
Medical Intelligence & Overview
Diabetes mellitus is a chronic health condition affecting how your body turns food into energy, resulting from either inadequate insulin production or the body's inability to use insulin properly. Among its complications, diabetic retinopathy is a serious eye condition caused by damage to the blood vessels in the retina, the part of the eye responsible for vision. When diabetes progresses to proliferative diabetic retinopathy, abnormal blood vessels grow on the retina, potentially leading to vision loss. The code E13.355 specifically describes a type of diabetes—other specified diabetes mellitus—that is accompanied by stable, proliferative diabetic retinopathy. This indicates that while the retinopathy is proliferative in nature, it remains stable with no active progression.
Causes & Symptoms
Clinical Causes: Chronic high blood sugar levels damaging blood vessels in the eyes Long-standing diabetes leading to vascular changes in the retina Poor control of blood glucose levels over time Presence of other metabolic factors, such as high blood pressure or high cholesterol, that exacerbate vascular damage
Key Symptoms: Sudden or gradual loss of vision Floaters or spots in the vision caused by bleeding from abnormal blood vessels Blurred or distorted vision Dark or empty areas in the visual field Difficulty seeing at night
Diagnostic & Treatment
Diagnosis Path: The diagnosis of proliferative diabetic retinopathy involves comprehensive eye examinations by a specialized ophthalmologist. Key diagnostic tools include dilated fundus exams, where eye drops widen the pupil to allow detailed view of the retina, and imaging tests such as fluorescein angiography. This imaging involves injecting a dye to highlight vessels in the retina and detect abnormal growths or bleeding. Ocular coherence tomography (OCT) may also be used to assess retinal thickness and detect fluid accumulation. The diagnosis considers the appearance of abnormal blood vessels and other retinal changes indicative of the proliferative stage.
Treatment Protocols: Managing diabetic retinopathy, especially the proliferative type, aims to prevent vision loss and control underlying blood sugar levels. Typical treatments include: - **Laser therapy (pan-retinal photocoagulation):**to shrink abnormal blood vessels and reduce bleeding risk. - **Intravitreal injections:** such as anti-VEGF (vascular endothelial growth factor) medications, to inhibit abnormal vessel growth. - **Vitrectomy:** a surgical procedure to remove blood or scar tissue from the vitreous gel when bleeding is severe. - **Blood sugar management:** Tight control of blood glucose levels through medication, diet, and lifestyle modifications. - Regular eye examinations** to monitor disease progression and adjust treatments accordingly. It is crucial for individuals with diabetic retinopathy to work closely with their healthcare team to optimize overall diabetes management and minimize complications.
Clinical Advice & FAQs
Billing Guidance
Is E13.355 a billable ICD-10 code?
Yes, E13.355 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E13.355?
Clinical documentation must specify the nature of Other specified diabetes mellitus with stable proliferative diabetic retinopathy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference